Robert Andrade, CHIEF FINANCIAL OFFICER at FENNEC PHARMACEUTICALS INC. (FENC), sold 75,000 shares at $11.78 ($884K) on 2026-08-27, disclosed to the SEC on 2026-08-28.
Scheduled sale ($884k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FENC | SELL | 2024-01-05 | $316K | — | Filing → |
| FENC | SELL | 2023-06-30 | $223K | — | Filing → |
| FENC | SELL | 2022-12-30 | $211K | — | Filing → |